Therefore, it is also conceivable that downregulation of differentiation markers (in RD and CRL2061) and the cell cycle arrest after FH535 treatment followed by apoptosis induction are rather mediated by PPARG in the RMS tumor cells than by β-catenin. Here, PPARG is linked to neoplasm.